Ambrose, J. A., D’Agate, D. J. et al. Plaque rupture and intracoronary
thrombus in nonculprit vessels. J. Am. Coll. Cardiol, 45:959–660,
2005. Andersen, H. R., Nielsen, T. T., Vesterlund, T., et al. Danish multicenter
randomized study on fibrinolytic therapy versus acute coronary
angioplasty in acute myocardial infarction: rationale and design of
the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2).
Am. Heart. J., 146:234–241, 2003. Andersen, H. R et al. A comparison of coronary angioplasty with
fibrinolytic therapy in acute myocardial infarction. N. Engl. J. Med.,
349:733–742, 2003. Antoniucci, D., Rodriguez, A., Hempel, A. et al. A randomized trial
comparing primary infarct artery stenting with or without abciximab
in acute myocardial infarction.J. Am. Coll. Cardiol, 42:1879–1885,
2003. ASSENT-3: Assessment of the Safety and Efficacy of a New Thrombolytic
Regimen Investigators. Efficacy and safety of tenecteplase in
combination with enoxaparin, abciximab, or unfractionated heparin:
The ASSENT-3 randomised trial of acute myocardial infarction.
Lancet, 358:605–613, 2001. Braunwald, E. Application of current guidelines to the management
of unstable angina and non-ST-elevation myocardial infarction.

Страницы: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12